In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 201 to 210 of 389

TitleTypeExpected publication date
Mepolizumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils [ID1237]Technology appraisal guidance
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)NICE guideline
Middle meningeal artery embolisation for chronic subdural haematomasInterventional procedures guidance
Mirdametinib for treating symptomatic inoperable plexiform neurofibromas in people 2 years and over with neurofibromatosis type 1 [ID6618]Technology appraisal guidance
Mirvetuximab soravtansine for previously treated platinum-resistant FR-alpha positive ovarian cancer [ID1527]Technology appraisal guidanceTBC
Mirvetuximab soravtansine for treating folate receptor alpha-positive platinum-resistant advanced epithelial ovarian, fallopian tube or primary peritoneal cancer [ID6442]Technology appraisal guidance
Monofocal intraocular lenses for cataract surgeryHealth technology evaluation
Mozafancogene autotemcel for treating Fanconi anaemia in people 1 to 17 years [TSID12203]Technology appraisal guidanceTBC
MTX110 for untreated diffuse intrinsic pontine glioma [ID2695]Technology appraisal guidanceTBC
Multidisciplinary care of children and young people with achondroplasiaNICE review

Results per page

  1. 10
  2. 25
  3. 50
  4. All